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The reactions of aryl isoselenocyanates 1 with 3-chloropropan-1-ol (8) in the presence of
sodium hydride in dichloromethane at room temperature gave 1,3-oxaselenan-2-imines
10 in fair yield. A reaction mechanism via nucleophilic attack of the alcoholate at the
isoselenocyanate 1, followed by an 6-exo-tet cyclization, is most likely.
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Selenium-containing heterocycles are of increasing interest because of their
unique biological and pharmaceutical activities, e.g., as antitumor, antibacterial,
and antiviral compounds, as enzyme inhibitors, and antioxidants [1]. Therefore, safe
procedures for their synthesis, and easily accessible, stable and less toxic selenium
reagents are much sought-after. In the last few years, we have shown that isoseleno-
cyanates fulfil these conditions to a large extent, as they are easy to prepare [2] and
are safe to handle and to store. Furthermore, they usually react under mild conditions,
which are compatible with low stability of substrates and are tolerated by various
functional groups. As a part of our research program aiming at developing new and
simple procedures for the synthesis of selenium-containing heterocycles (see [3,4]),
we have shown that aryl isoselenocyanates 1 are convenient precursors for the in-
troduction of selenium into four [5] (see also [6]), five [7,8], six [7,9,10], and
seven-membered selenaheterocycles [11]. The general concepts for the syntheses
are shown in Scheme 1. The addition of a nucleophile 2, which bears also a leaving
group, leads to the intermediate 3. Cyclization of the latter via the more nucleophilic
Se-atom yields the selenaheterocycle of type 4. The same concept has been used by
Koketsu et al. for the synthesis of 5-methylene-1,3-selenazolidin-2-imines from 1
and propargylamine [12]. Alternatively, the adduct 5 of a bis-nucleophile, e.g.,
hydrazine, reacts with a bis-electrophile to give 6, which undergoes a ring-closure
to yield 7.
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To the best of our knowledge, no report on the preparation of 1,3-oxaselenane ex-
ists, and only a few papers concern fused benzo-1,3-oxaselenanes [13]. Furthermore,
there is not much known about O,Se-containing heterocycles in general, and most pa-
pers are devoted to molecular and analytical studies [14,15] and the synthesis of
1,4-oxaselenanes using potassium selenocyanate [16], selenium oxide [17], or hy-
drogen selenide [18].
In the present paper, we report the first synthesis of 2-imino-1,3-oxaselenanes by
using aryl isoselenocyanates 1.
RESULTS AND DISCUSSION
According to the general concept depicted in Scheme 1, we aimed at the prepara-
tion of 1-oxa-3-selenaheterocycles by the reaction of -haloalkan-1-ols with aryl
isoselenocyanates 1. Therefore, a mixture of 1 and 3-chloropropanol (8) in dichloro-
methane at room temperature was treated with an equimolar amount of sodium hy-
dride, and the mixture was stirred for 3–4 h
*
. After chromatographic work up, an oily
product, which contains aromatic as well as aliphatic H-atoms (
1
H-NMR), was ob-
tained in 36–60% yield. Mass spectrometry and elemental analysis confirmed that
the two starting materials had reacted to yield the product by elimination of HCl.
As we expected that the addition of the anion of 8 to 1 gives the intermediate 9
(Scheme 2), there are two possibilities for the cyclization reaction to be discussed:
nucleophilic substitution of the chloride by the selenide would lead to 2-imino-
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Scheme 1
*It has to be noted that only this procedure led to a reaction between 1 and 8 . All attempts to prepare the
alcoholate first led to reactions of the alcoholate with 8.
1,3-oxaselenane 10 (path a)), whereas the analogous cyclization via the N-atom
would yield 1,3-oxazinane-2-selones 11 (path b)). Both pathways are based on an
6-exo-tet cyclization [19], and both have been observed previously in similar re-
actions, i.e. path a) [4–12] and path b) [20–22].
On the basis of their spectroscopic data, the structure for the products was deter-
mined as 10. For example, 10a shows a strong IR absorption at 1662 cm
–1
(C=N);
the corresponding absorption of the N-analogue 12 appears at 1630 cm
–1
[10] (see
also [9]). The 1H- and 13C-NMR spectra of 10a are very similar to those of
the 1,3-selenazinan-2-imines 12 [10] (Figure 1). The only significant differences
concern C(2) and C(6), i.e., the neighboring atoms of the O-atom, which are shifted
to lower field. Furthermore, the H-atoms at C(6) absorb at 4.26 ppm in 10a com-
pared with 3.41 ppm in 12. In the alternative structure 11 (Scheme 2), C(2) as well
as C(4) should absorb at significantly lower field; the 13C-absorptions for C(4), C(5),
and C(6) of 11 would be expected at ca. 45, 24, ad 70 ppm, respectively.
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Figure 1. Chemical shifts (ppm) of H- and C-atoms of 10a and 12 in CDCl3.
All attempts to generalize the reaction toward the synthesis of 5- and 7-mem-
bered analogues of 10 failed. Neither in the case of 2-haloethanol nor in the case of
4-halobutan-1-ol could addition products be obtained.
In conclusion, we have shown that the base-catalyzed reaction of 3-chloro-
propan-1-ol (8) with aryl isoselenocyanates 1 yields derivatives of the practically un-
known 1,3-oxaselenanes. The synthesis uses 1 as an easily accessible and safe
selenium-containing starting material, which is smooth to handle.
EXPERIMENTAL
1. General. Thin layer chromatography (TLC): silica gel 60 F254 plates (0.25 mm; Merck). Column
chromatography (CC): silica gel 60 (0.040–0.063 mm; Merck). Melting points (M.p.) were determined in
capillaries on a Büchi B-540 apparatus and are not corrected. The IR spectra were registered on a
Perkin-Elmer 1600-FT-IR spectrometer (as film). The NMR spectra were recorded in CDCl3 solutions on
a Bruker ARX-300 instrument (
1
H: 300 MHz;
13
C: 75.6 MHz); chemical shifts in ppm relative to internal
TMS. The 13C- NMR spectra were recorded by using DEPT registration. The CI-MS spectra were regis-
tered with a Finnigan SSQ-700 or MAT-90 instrument; NH3 was used as a carrier gas.
2. Starting materials. 3-Chloropropan-1-ol (8) and sodium hydride (95%) are commercially
available (Fluka and Aldrich). Isoselenocyanates 1a–d were prepared according to Bartons procedure [2]
starting from formamides. Formanilide is commercially available (Fluka and Aldrich) while N-(4-chlo-
rophenyl)-, N-(4-bromophenyl)-, and N-(4-methylphenyl)formamide were prepared from the respective
commercial aniline and 95% formic acid [23]. The solution was heated to reflux for 30 min and evapo-
rated to dryness in vacuo. The residue was dissolved in ether and washed with diluted acetic acid (5%),
water, and aqueous NaHCO3 (5%). The aqueous layer was extracted with ether, the combined organic ex-
tracts were dried with MgSO4 and evaporated under reduced pressure. The crude products were purified
by recrystallization in ethanol/water.
3. General procedure for the synthesis of 1,3-oxaselenan-2-imines. A 25 mL round-bottom
flask equipped with magnetic stirrer and condenser was charged with a mixture of an isoselenocyanate
1 (1.0 mmol) and 3-chloropropan-1-ol (8 , 1.0 mmol) in dichloromethane (20 ml). Then, sodium hydride
(ca. 1.0 mmol) was added, the reaction mixture was stirred for 3 to 4 h at room temperature and evaporated
to dryness under reduced pressure. The crude product was purified by column chromatography on silica
gel using hexane/ethyl acetate (100/0 to 50/50) as eluent.
(1,3-Oxaselenan-2-ylidene)(phenyl)amine (10a). Yield: 86.5 mg (36%), yellow oil. IR (film):
3442m (br), 3060w, 2926w, 1726w, 1662s, 1628s, 1592s , 1539w, 1493m, 1441w, 1371w, 1288w, 1231m,
1150w, 1067w, 1023w, 1002w, 866w, 765m, 696s .
1
H-NMR (CDCl3): 2.03–2.13 (m, CH2); 2.93 (t, J = 7.2,
CH2); 4.26 (t, J = 7.2, CH2); 6.82 (d, J = 8.1, 2 arom. H); 7.01 (t, J = 8.1, 2 arom. H); 7.22 (d, J = 8.1, 1
arom. H).
13
C-NMR (CDCl3): 20.2 (CH 2); 23.2 (CH2); 70.1 (CH2 ); 121.3 (2 arom. CH); 124.1 (1 arom.
CH); 129.0 (2 arom. CH); 146.8 (arom. C); 152.7 (C=N). CI-MS: 244 (18), 243 (12), 242 (100,
[M(
80
Se)+1]
+
), 241 (14), 240 (53), 239 (23), 238 (22). Anal. Calc. for C10H11NOSe (240.17): C 50.01, H
4.62, N 5.83. Found: C 49.88, H 4.45, N 6.01.
(4-Bromophenyl)(1,3-oxaselenan-2-ylidene)amine (10b). Yield: 127.6 mg (40%), orange oil. IR
(film): 3442w (br), 3234w, 3102w, 3030w, 2960w, 1694w, 1652s , 1597w, 1586w, 1552m , 1486s, 1440w,
1423w, 1393 m, 1302m, 1285m , 1260w, 1245m, 1159m, 1111w, 1099 w, 1069m, 1009m, 881w, 814m,
798m, 714w, 652w, 615w.
1
H-NMR (CDCl3): 2.10–2.21 (m , CH2); 3.01 (t, J = 7.2, CH2); 4.33 (t, J= 7.2,
CH2); 6.74, 7.37 (AA’BB’, J = 8.1, 4 arom. H).
13
C-NMR (CDCl 3): 20.4 (CH2); 23.2 (CH2); 70.2 (CH2);
117.1 (1 arom. C); 123.2 (2 arom. CH); 132.1 (2 arom. CH); 145.8 (1 arom. C); 153.2 (C=N). CI-MS: 324
(12), 323 (10), 322 (76), 321 (19), 320 (100, [M (
80
Se,
79
Br)+1]
+
), 319 (26), 318 (47), 317 (17), 316 (16).
Anal. Calc. for C10H10BrNOSe (319.01): C 37.64, H 3.16, N 4.39. Found: C 37.77, H 3.22, N 4.12.
(4-Chlorophenyl)(1,3-oxaselenan-2-ylidene)amine (10c). Yield: 129.78 mg (47%), orange oil. IR
(film): 3425w (br), 2928w, 2857w, 1726w, 1662s, 1628 s, 1589m, 1532w, 1489s, 1435w, 1401w, 1371w,
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1235m (br), 1172w, 1151w, 1091m, 1066w, 1012m, 877w, 831m, 720w. 1H-NMR (CDCl3): 2.17–2.33 (m,
CH2); 3.08 (t, J = 7.2, CH2); 4.39 (t, J = 7.2, CH2); 6.85, 7.29 (AA’BB’, J = 8.1, 4 arom. H).
13
C-NMR
(CDCl3): 20.3 (CH2); 23.2 (CH2); 70.2 (CH2); 122.7 (2 arom. CH); 129.1 (2 arom. CH); 130.8 (1 arom. C);
145.3 (1 arom. C); 154.2 (C=N). CI-MS: 278 (44), 277 (12), 276 (100, [M (80Se)+1]+), 275 (12), 274 (49),
273 (16), 272 (17). Anal. Calc. for C10H10NOSeCl: C 43.74, H 3.67, N 5.10. Found: C 43.88, H 3.54,
N 5.20.
(4-Methylphenyl)(1,3-oxaselenan-2-ylidene)amine (10d). Yield: 152.5 mg (60%), orange oil. IR
(film): 3424w (br), 3301w, 3038w, 2924m, 2866w, 1722w, 1696m, 1664s , 1602w, 1511s, 1441w, 1406w,
1372w, 1313w, 1288w, 1235m (br), 1178w, 1107w, 1066w, 877w, 819s, 720m. 1H-NMR (CDCl3):
2.19–2.30 (m, CH2); 2.32 (s, CH3); 3.02 (t, J = 7.2, CH2); 4.36 (t, J = 7.2, CH2); 6.87, 7.10 (AA’BB’, J =
8.1, 4 arom. H).
13
C-NMR (CDCl3): 20.1 (CH2); 20.8 (CH3 ); 23.3 (CH2); 70.0 (CH2); 119.2 (1 arom. C);
121.1 (2 arom. CH): 129.6 (2 arom. CH); 133.0 (1 arom. C); 144.1 (1 arom. C); 153.0 (C=N). CI-MS: 258
(18), 257 (15), 256 (100, [M(
80
Se)+1]
+
), 255 (24), 254 (51), 253 (27), 252 (23), 251 (4). Anal. Calc. for
C11H13NOSe (254.20): C 51.98, H 5.15, N 5.51. Found: C 52.28, H 5.02, N 5.87.
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